This may seem a rather low uptake, but a recent study using an 111In-labeled anti-ERC/mesothelin mouse monoclonal IgG2a did not exceed 5.8%ID/g in the tumor at any time point of 24, 48 or 96 h [12]. This evidence concerns the gene MSLN and neoplasm.